Oncotarget · 2020 · 24 citations · 54 references
MedicineCancer BiologyOncologyInflammationMolecular OncologyTumor MicroenvironmentInflammation-associated CarcinogenesisInflammatory SignalingLung CancerMalignant NeoplasmsTumor Microenvironment ModulationCyclooxygenase-2 PathwayInflammation-mediated CarcinogenesisInflammatory Pathway DysregulationMicrorna In CancerMicrorna Regulation In CancerMicrosomal Prostaglandin E SynthaseProstaglandin E2 BiosynthesisProstaglandin Production
// Nicholas J. Monteleone 1 and Carol S. Lutz 1 1 Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers Biomedical & Health Sciences, New Jersey Medical School, School of Graduate Studies, Newark, NJ 07103, USA Correspondence to: Carol S. Lutz, email: lutzcs@njms.rutgers.edu Keywords: miR-708-5p; miR-708; lung cancer; COX-2; mPGES-1 Received: March 27, 2020     Accepted: May 14, 2020     Published: June 30, 2020 ABSTRACT Many cancers maintain an inflammatory microenvironment to promote their growth. Lung cancer is of particular importance, as it is the deadliest cancer worldwide. One inflammatory pathway commonly dysregulated in cancer is the metabolism of arachidonic acid (AA) by Cyclooxygenase-2 (COX-2) and microsomal Prostaglandin E Synthase 1 (mPGES-1) into Prostaglandin E2 (PGE 2 ). While researchers have identified PGE 2 ’s pro-tumorigenic functions, the mechanisms governing overexpression of COX-2 and mPGES-1 are incompletely understood. MicroRNAs (miRNAs) are important post-transcriptional regulators commonly dysregulated in cancer. Interestingly, miR-708-5p (miR-708) is predicted to target both COX-2 and mPGES-1. In this study, we show that high miR-708 expression is associated with survival rates in lung squamous cell carcinoma patients. miR-708 also represses PGE 2 production by suppressing both COX-2 and mPGES-1 expression in lung cancer cells. miR-708 regulation of COX-2 and mPGES-1 is mediated through targeting of their 3′ untranslated regions (UTRs). Moreover, miR-708 decreases proliferation, survival, and migration of lung cancer cells, which can be partially attributed to miR-708’s inhibition of PGE 2 signaling. Lastly, we identify novel miR-708 predicted targets and possible regulators of miR-708 expression in lung cancer. Collectively, these data demonstrate that dysregulated miR-708 expression contributes to exacerbated PGE 2 production, leading to an enhanced pro-tumorigenic phenotype in lung cancer cells.
54
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text
Life Sciences, Immunology, Oncology +17
Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation
Shveta Bagga, John R. Bracht, Shaun Hunter et al. · Cell · 2005 · 1.3K citations · Full text
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Hongmiao Sheng, Jian‐Hua Shao, Jason D. Morrow et al. · PubMed · 1998 · 1.1K citations
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay, Annemarthe G. van der Veen, Jan P. Böttcher et al. · Cell · 2015 · 1.1K citations · Full text
Medicine, Immunology, Oncology +17
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
Tong‐Chuan He, Timothy A. Chan, B Vogelstein et al. · Cell · 1999 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +16